Dr. K Anand Kumar

Managing Director, Indian Immunologicals Ltd, Hyderabad, India

 

Dr. K Anand Kumar has a Ph.D in Microbiology from Indian Council of Medical Research (ICMR) and has over 25 years of experience in the biotechnology/pharma Industry.

Dr. Kumar is currently the Managing Director at Indian Immunologicals Ltd (IIL). Indian Immunologicals Ltd, a subsidiary company of National Dairy Development Board (NDDB), is the largest veterinary vaccine company in India and the 3rd largest human vaccine company in India. He is a whole time Director on the board of IIL and is also a director at its subsidiary Pristine Biologicals NZ Ltd.

Prior to IIL, Dr.Kumar worked as Associate Vice President – biotech operations at Wockhardt Ltd.

He has worked for more than a decade outside India for companies such as Pfizer Global Manufacturing in Australia and Schering Plough Animal Health in New Zealand. He also had a brief stint as Investment Manager-biotech with the New Zealand Government.

Dr.Kumar is a member of the National Biotechnology Expert Committee with FICCI and CII and he is a member of the National Pharmaceutical Committee with CII. He was an executive committee member of Parenteral Drug Association (PDA), Australia and currently is on the expert panel on analytical methods related to vaccines with the Indian Pharmacopeia (IP). He served as an expert volunteer with United States Pharmacopeia (USP) during the period 2010-15. He has been a speaker at various international forums.

Dr.Kumar undertook Senior Management Development Programme at the Indian Institute of Management, Ahmedabad.

He has vast experience in various fields related to the biotech/vaccine Industry including Project management, Bioprocess manufacturing, Advanced Fill Finish processes, Technology transfer, Quality control, Quality assurance, R&D, Cold chain management, TQM, Industrial safety, Biosecurity etc.

He has actively contributed to the commercialization of various recombinant biotech products including hepatitis B vaccine, recombinant Human Insulin, Erythropoietin, Insulin Glargine, Interferon., Epidermal Growth Factor. He has handled products belonging to all three major expression systems such as yeast, bacteria and mammalian cells.

He is listed in the top 40 influencers in the Indian biopharmaceutical industry by Terrapin, a leading consultancy firm from Singapore in 2013.